학술논문
LBA13Prognostic impact of anthracyclines and immune/proliferation markers in TNBC according to pCR after de-escalated neoadjuvant chemotherapy with 12 weeks of nab-paclitaxel/carboplatin or gemcitabine: Survival results of WSG-ADAPT-TN phase II trial.
Document Type
Article
Author
Source
Subject
*CANCER chemotherapy
*TRIPLE-negative breast cancer
*
Language
ISSN
0923-7534